Persistent goiter with congenital hypothyroidism due to mutation in DUOXA2 gene
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Thyroid hormones are crucial for development of the central nervous system. Congenital hypothyroidism (CH) is the most common preventable disease resulting in mental retardation. A neonatal screening test (NST) can detect a mild form of CH that can be treated at an early age. Generally after 3 years of age, when most of the brain has matured, clinicians consider reevaluation of thyroid function for CH patients that have been identified with a normal thyroid gland at a normal position. This report presents three CH patients that developed normally, with persistent goiter despite thyroid hormone supplements. The patients’ initial thyroid-stimulating hormone (TSH) level after NST was 47, 157, and 57 mIU/L, respectively. Levothyroxine administration began at 1 or 2 months of age and was terminated after reevaluation at the age of 3, 15, and 5 years, respectively. However, 1 or 2 years later, they all resumed their medication due to increased TSH level coupled with newly developed or enlarged goiter. They all showed dual oxidase maturation factor 2 (DUOXA2) gene mutation: a homozygous mutation with DUOXA2 (c.413dupA; p.Tyr138*) in case 1, a presumed compound heterozygotic mutation with DUOXA2 (p.Tyr138*/p.Tyr246*) in case 2, and heterozygous mutations with DUOXA2 (c.738C>G; p.Tyr246*) and TPO (c.2268dupT; p.Glu757*) in case 3. When goiter persists or is newly developed despite a maintained euthyroid status, for those with transient CH history, follow-up to assess the thyroid function is recommended for at least 1 or 2 years, and genetic testing would be helpful. This study presents the first clinical cases of DUOXA2 mutation in Korea.
Abstract
Thyroid hormones are crucial for development of the central nervous system. Congenital hypothyroidism (CH) is the most common preventable disease resulting in mental retardation. A neonatal screening test (NST) can detect a mild form of CH that can be treated at an early age. Generally after 3 years of age, when most of the brain has matured, clinicians consider reevaluation of thyroid function for CH patients that have been identified with a normal thyroid gland at a normal position. This report presents three CH patients that developed normally, with persistent goiter despite thyroid hormone supplements. The patients’ initial thyroid-stimulating hormone (TSH) level after NST was 47, 157, and 57 mIU/L, respectively. Levothyroxine administration began at 1 or 2 months of age and was terminated after reevaluation at the age of 3, 15, and 5 years, respectively. However, 1 or 2 years later, they all resumed their medication due to increased TSH level coupled with newly developed or enlarged goiter. They all showed dual oxidase maturation factor 2 (DUOXA2) gene mutation: a homozygous mutation with DUOXA2 (c.413dupA; p.Tyr138*) in case 1, a presumed compound heterozygotic mutation with DUOXA2 (p.Tyr138*/p.Tyr246*) in case 2, and heterozygous mutations with DUOXA2 (c.738C>G; p.Tyr246*) and TPO (c.2268dupT; p.Glu757*) in case 3. When goiter persists or is newly developed despite a maintained euthyroid status, for those with transient CH history, follow-up to assess the thyroid function is recommended for at least 1 or 2 years, and genetic testing would be helpful. This study presents the first clinical cases of DUOXA2 mutation in Korea.
참고문헌 (20)
- LaFranchi SH, "Increasing incidence of congenital hypothyroidism : some answers, more questions", J Clin Endocrinol Metab, 96, pp.2395~2397 (2011)
- Maruo Y, "Natural course of congenital hypothyroidism by dual oxidase 2 mutations from the neonatal period through puberty", Eur J Endocrinol, 174, pp.453~463 (2016)
- Hanley P, "Thyroid disorders in children and adolescents : a review", JAMA Pediatr, 170, pp.1008~1019 (2016)
- Szinnai G, "Clinical genetics of congenital hypothyroidism", Endocr Dev, 26, pp.60~78 (2014)
- Oron T, "Permanent vs transient congenital hypothyroidism : assessment of predictive variables", J Clin Endocrinol Metab, 103, pp.4428~4436 (2018)
- 박일순, "Predictors of transient congenital hypothyroidism in children with eutopic thyroid gland", Annals of Pediatric Endocrinology & Metabolism, 22(2), pp.115~118 (2017), 대한소아내분비학회
- Persani L, "Genetics and management of congenital hypothyroidism", Best Pract Res Clin Endocrinol Metab, 32, pp.387~396 (2018)
- 박경진, "DUOX2 Mutations Are Frequently Associated With Congenital Hypothyroidism in the Korean Population", Annals of Laboratory Medicine, 36(2), pp.145~153 (2016), 대한진단검사의학회
- Hulur I, "A single copy of the recently identified dual oxidase maturation factor (DUOXA) 1 gene produces only mild transient hypothyroidism in a patient with a novel biallelic DUOXA2 mutation and monoallelic DUOXA1deletion", J Clin Endocrinol Metab, 96, pp.E841~E845 (2011)
- Weber G, "Genetic defects of hydrogen peroxide generation in the thyroid gland", J Endocrinol Invest, 36, pp.261~266 (2013)
- Zamproni I, "Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism", J Clin Endocrinol Metab, 93, pp.605~610 (2008)
- Corvilain B, "The H2O2-generating system modulates protein iodination and the activity of the pentose phosphate pathway in dog thyroid", Endocrinology, 128, pp.779~785 (1991)
- Liu S, "A novel missense mutation(I26M)in DUOXA2 causing congenital goiter hypothyroidism impairs NADPH oxidase activity but not protein expression", J Clin Endocrinol Metab, 100, pp.1225~1229 (2015)
- Sugisawa C, "Homozygous DUOXA2 mutation (p.Tyr138(*)) in a girl with congenital hypothyroidism and her apparently unaffected brother: case report and review of the literature", Endocr J, 64, pp.807~812 (2017)
- Yasumoto M, "Simple new technique for sonographic measurement of the thyroid in neonates and small children", J Clin Ultrasound, 32, pp.82~85 (2004)
- Yi RH, "A novel dual oxidase maturation factor 2 gene mutation for congenital hypothyroidism", Int J Mol Med, 31, pp.467~470 (2013)
- Tanase-Nakao K, "Fetal goitrous hypothyroidism and polyhydramnios in a patient with compound heterozygous DUOXA2 mutations", Horm Res Paediatr, 90, pp.132~137 (2018)
- Morand S, "Duox maturation factors form cell surface complexes with Duox affecting the specificity of reactive oxygen species generation", FASEB J, 23, pp.1205~1218 (2009)
- Moreno JC, "Ris-Stalpers C. Cloning of tissue-specific genes using serial analysis of gene expression and a novel computational substraction approach", Genomics, 75, pp.70~76 (2001)
- Jin HY, "High frequency of DUOX2 mutations in transient or permanent congenital hypothyroidism with eutopic thyroid glands", Horm Res Paediatr, 82, pp.252~260 (2014)